Log in

RegulatoryCNBC-TV18

USFDA classifies Cohance Telangana facility as voluntary action indicated

Negative-33

GreyOak summary

The USFDA concluded its inspection of Cohance Lifesciences' Telangana facility, classifying the findings as 'Voluntary Action Indicated.' An Establishment Inspection Report was issued, noting issues requiring voluntary corrective action but no immediate regulatory enforcement. The company stated the inspection is now concluded.

What it affects

Source

Reported by CNBC-TV18

More Cohance Lifesciences news

No other recent stories about Cohance Lifesciences.

All Cohance Lifesciences news →

The company today

Price, day change, sector and market cap of the companies this story names
CompanyPriceDay changeSectorMarket cap
Cohance LifesciencesCOHANCE · NSE₹462.30+0.62%Healthcare₹17,687 crore

Prices as of ; the last session's close when the market is shut. Research, not investment advice.

Latest market news

News Intelligence →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy